全球活检设备市场 - 市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033 年）

全球癌症发生率的增加是活检设备市场的主要驱动因素之一。 患病率的不断增加增加了对有效诊断治疗的需求并影响了市场成长。 对微创手术的需求也促进了活检设备市场的发展。 技术的进步，特别是具有改进功能的活检设备，例如更高的准确性、更快的患者復健和微创手术，可以带来更安全的手术。 促进诊断的政府计划预计将提高诊断设备的使用率。

本报告研究和分析了全球活检设备市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

商用切片设备和不断变化的竞争格局

• 对主要产业趋势的考虑
• 按活检设备市场细分的年收入和市场前景（2015-2033 年）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 切片设备市场的SWOT分析
• 切片设备市场竞争动态的考量与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Becton Dickinson and Co
• Danaher Corp
• Hologic Inc
• Cook Group Inc
• Boston Scientific Corp
• Medtronic Plc
• ConMed Corp
• Olympus Corp
• Weigao Group Co Ltd
• Henry Schein Inc
• Coloplast A/S
• Merit Medical Systems Inc
• Integra LifeSciences Holdings Corp
• Teleflex Inc
• Acuderm Inc
• Steris Plc
• 其他

Abstract

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Biopsy Devices market for the year 2020 and beyond. A biopsy device is an instrument that aids in the removal of tissue samples from the body. Increasing global cancer incidence is one of the primary drivers of the biopsy devices market. Increasing prevalence results in a growing need for effective diagnostic procedures, which in turn, impacts market growth. Demand for the minimal invasive procedure has also contributed to the biopsy devices market. Advances in technology, especially biopsy devices with improved features such as enhanced accuracy, quicker recovery of patients, and less traumatic procedures, will result in safer procedures. Government programs to promote diagnosis is expected to improve the utilization of diagnostic devices.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Biopsy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Biopsy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Biopsy Devices market.
• Competitive dynamics insights and trends provided for Biopsy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Becton Dickinson and Co, Danaher Corp, Hologic Inc, Cook Group Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Weigao Group Co Ltd, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, Steris Plc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Biopsy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Biopsy Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Biopsy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Biopsy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Biopsy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable